A Phase IV, Open-label, Multi-center, Community-based Trial Studying the Safety and Efficacy of Keppra as Adjunctive Therapy in Adult Subjects With Uncontrolled Partial Epilepsy.

Trial Profile

A Phase IV, Open-label, Multi-center, Community-based Trial Studying the Safety and Efficacy of Keppra as Adjunctive Therapy in Adult Subjects With Uncontrolled Partial Epilepsy.

Completed
Phase of Trial: Phase IV

Latest Information Update: 30 Oct 2014

At a glance

  • Drugs Levetiracetam (Primary)
  • Indications Partial epilepsies
  • Focus Adverse reactions
  • Sponsors UCB Pharma Inc
  • Most Recent Events

    • 16 Jul 2007 Status change from in progress to completed.
    • 30 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top